Has Katherine Hall received payments from drug or device companies?

Yes. Drug and device makers reported $1,633 in general payments to Katherine Hall across 36 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Katherine Hall did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Katherine Hall come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Katherine Hall

Physician Assistant · Post Falls, IDNPI 1366497547

Payments from drug & device makers

$1,633in general payments, 2019–2025

Across 36 payments — averaging $45.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Radius Health, Inc.$321
Novo Nordisk$257
Amgen$216
Ascendis Pharma Endocrinology Inc$215
BETA Bionics, Inc.$147
Sequel Med Tech, LLC$142
plus $334 from 5 others

What the payments were for

Food & beverage$1,633100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Radius Health, Inc.	5	$321
Novo Nordisk	12	$257
Amgen	3	$216
Ascendis Pharma Endocrinology Inc	4	$215
BETA Bionics, Inc.	2	$147
Sequel Med Tech, LLC	1	$142
AstraZeneca	3	$108
Tandem Diabetes Care, Inc.	2	$82
Insulet Corporation	2	$61
Kyowa Kirin, Inc.	1	$60
Abbott	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

iLet Bionic Pancreas$388
TWIIST$142
iLet Insulin Infusion Kit Inset$129
iLet Insulin Infusion Kit Contact Detach$129
EVENITY$125

How this compares

$1,633 in reported general payments places this provider in the 75th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho →

Medicare billing

Part B allowed, 2024

$58,696

Medicare patients

269

Services billed

721

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	210	$238,992
JardianceEmpagliflozin	86	$90,522
TymlosAbaloparatide	29	$88,479
Humalog Kwikpen U-200Insulin Lispro	26	$33,122
Tresiba Flextouch U-100Insulin Degludec	60	$31,889
MounjaroTirzepatide	26	$28,996
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7	25	$21,316
Fiasp FlextouchInsulin Aspart (Niacinamide)	12	$9,124
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	51	$8,827
Humalog Kwikpen U-100Insulin Lispro	28	$8,328
SynthroidLevothyroxine Sodium	64	$5,945
HumalogInsulin Lispro	15	$5,625
Novolog FlexpenInsulin Aspart	24	$5,469
Nano 2nd Gen Pen NeedlePen Needle, Diabetic	47	$5,373
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog	15	$4,857

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic	$257	$238,992210 claims
Radius Health, Inc.Tymlos	$321	$88,47929 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,027 physician assistant providers in Idaho.